PODCAST

Healthcare Policy

ReachMD

science & medicine medicine

All Episodes

00:00:00

Prescriptions for OTC Drugs? New Rules for Flexible...

Healthcare Policy ·

2011/01/05

Guest: Roland Goertz, MD Host: Bruce Japsen If patients take advantage of flexible spending accounts to help pay for their medical care, the health reform law is triggering some changes for them and doctor practices. Most notably, over the counter items like pain relievers and allergy meds will require a prescription. Host Bruce Japsen talks with Dr. Roland Goertz, president of the American Academy of Family Physicians about how patients and their doctors can prepare for these

00:00:00

Biomolecular Advances in Diabetes Prevention

Healthcare Policy ·

2010/11/01

Guest: Carmella Evans-Molina, MD, PhD Host: Bruce Bloom, DDS, JD As the epidemic of type 2 diabetes in the United States grows, researchers are investigating hundreds of ways to treat and cure diabetes. Some of these methods include exogenous insulin, while other ideas being explored require more complex changes in our understanding of cellular biology.Dr. Carmella Evans-Molina, assistant professor at the Indiana University School of Medicine, who holds a faculty appointment in the

00:00:00

Where Do SGLT-2s Fit in the Treatment of Diabetes?

Healthcare Policy ·

2010/10/28

Guest: Robert Henry, MD Host: Steven Edelman, MD The potential benefits of a new class of medications, sodium-dependent glucose cotransporter-2 therapy (or SGLT-2s), for type 2 diabetes is promising, but where will they fit in the treatment of diabetes and what are the risks? Join host Dr. Steven Edelman and his guest, professor of medicine at the Veterans Affairs Medical Center in San Diego, California, Dr. Robert Henry, as they discuss the mechanism, benefits and potential

00:00:00

Insulin Resistance and the Risk of Ischemic Stroke

Healthcare Policy ·

2010/10/27

Guest: Tatjana Rundek, MD, PhD Host: Maurice Pickard, MD Hundreds of millions of people may have insulin resistance worldwide. What is the connection between insulin resistance and the risk of ischemic stroke?Dr. Tatjana Rundek, associate professor of neurology and director of the clinical translational research division in the department of neurology of the Miller School of Medicine at the University of Miami, Florida, discusses her research on the risk of developing ischemic

00:00:00

Weighing Metformin's Benefits & Risks in Patients...

Healthcare Policy ·

2010/10/26

Guest: Hugh Tildesley, MD Host: Lee Freedman, MD Metformin is often the first line of therapy for patients with type 2 diabetes: it is relatively inexpensive, available, and has proven efficacy. However, metformin is contraindicated for patients with renal insufficiency, a common comorbidity in diabetes. Do the benefits of metformin outweigh the risks for those with renal insufficiency, or should we use caution when considering metformin for these patients?Dr. Hugh Tildesley,

00:00:00

Diabetes Research: Hope for a Cure in Stem Cells?

Healthcare Policy ·

2010/10/05

Guest: Emmanuel Baetge, PhD Host: Steven Edelman, MD Current stem cell therapy research is leading the way into producing functional pancreatic, insulin-producing cells. How will this translate into clinical trials and human therapy for diabetes from a scale, delivery and efficacy position? Join host Dr. Steven Edelman and his guest Dr. Emmanuel Baetge, chief scientific officer of Viacyte, Inc., as they discuss the benefits of stem cell research therapy for diabetes.

00:00:00

When PPIs Fail: Evaluating and Managing Patients with...

Healthcare Policy ·

2010/09/16

Guest: Brian Lacy, MD, PhD Host: Lee Freedman, MD Resistance to proton pump inhibitors, or PPIs, is not uncommon among patients with gastroesophogeal reflux disease, or GERD.How should physicians initially approach managing patients with suspected GERD, andat what point should physicians classify a patient as a PPI non-responder?Our guest, Dr.Brian Lacy, associate professor of medicine at Dartmouth Medical School, and director of the GI Motility Laboratory at Dartmouth-Hitchcock

00:00:00

Do We Need to Temper our Enthusiasm for...

Healthcare Policy ·

2010/09/13

Guest: Robert Cuddihy, MD Host: Steven Edelman, MD There have been impressive results with incretin-based therapy for patients with type 2 diabetes: improved A1C, beta-cell preservation and weight loss are some of the benefits. But do healthcare professionals need to temper their enthusiasm for this novel therapy? Join host Dr. Steven Edelman and his guest, medical director of the International Diabetes Center, Park Nicollet Health Services, Dr. Robert Cuddihy, as they discuss

00:00:00

The Urban Health Iniative: Re-Inventing Medical Care...

Healthcare Policy ·

2010/09/08

Guest: Eric Whitaker, MD Host: Bruce Japsen An initiative sprouting on the South Side of Chicago that was once led by First Lady Michelle Obama aims to become a national model for re-educating communities on everything from appropriate emergency department usage to outpatient care and healthy life choices. Dr. Eric Whitaker, executive vice president of strategic affiliations and associate dean of community-based research at the University of Chicago Medical Center, tells host Bruce

00:00:00

A More Resilient Health System in Katrina's Wake

Healthcare Policy ·

2010/09/01

Guest: Karen DeSalvo, MD Host: Bruce Japsen Five years after Hurricane Katrina, the horrific memories of disaster and devastation remain, but the healthcare system has created a legacy of resilience for the city's safety net and a potential national model beyond the primary care medical home. Dr. Karen DeSalvo, professor of medicine at the Tulane School of Medicine and a leader in the health system's post-Katrina recovery, tells host Bruce Japsen about the new community-based

00:00:00

The Impact of Pharmacy Issues in Long-Term Care

Healthcare Policy ·

2010/08/30

Guest: Frederick Wendt, RPh Host: Eric Tangalos, MD As medication costs continue rising, what strategies can help long-term care facilities reduce drug expenditures, while still providing the best quality of care for patients? Fred Wendt, RPh, vice president of pharmacy services for Senior PharmaStrategies in Burleson, Texas, says one of the most significant pharmacy issues in long-term care is the Drug Enforcement Administration's current position on the nursing facility staff as

00:00:00

Health Reform and Myths About the Emergency Department

Healthcare Policy ·

2010/08/25

Guest: Angela Gardner, MD Host: Bruce Japsen As healthcare reforms take place, changes are also in the offing in the emergency department amid demands that EDs be able to turn attention from treatment of routine conditions to disasters and other true emergencies. Dr. Angela Gardner, president of the American College of Emergency Physicians, tells host Bruce Japsen about tomorrow's needs for the emergency department, which will have a greater role as health reform is implemented and

00:00:00

Health Effects of the Gulf Oil Spill

Healthcare Policy ·

2010/08/24

Guest: Maureen Lichtveld, MD, MPH Host: Maurice Pickard, MD Long after the clean-up process from the Deepwater Horizon oil spill is complete along the Gulf of Mexico, we'll still be examining the health effects of this catastrophe. While there is a wealth of information on the health effects of specific contaminants, the effects are less known regarding mixtures of contaminants. What are some of the immediate and potential long-term health risks (both mental and physical) of this

00:00:00

Expanding the Anti-Arrhythmia Armamentarium: Where...

Healthcare Policy ·

2010/08/03

Guest: Sanjay Kaul, MD, MPH Host: Janet Wright, MD Atrial-fibrillation, or a-fib, affects nearly 2.5 million patients in the US, and is one of the more common forms of arrhythmia. The antiarrhythmic armamentarium has been expanded to include dronedarone, which was recently approved by the FDA for the treatment of a-fib. What's the efficacy and safety of dronedarone, compared to other antiarrhythmic agents, and how should you use it?Dr. Sanjay Kaul, director of the Vascular

00:00:00

Making the Connection Between Vitamin D, Falls and...

Healthcare Policy ·

2010/08/03

Guest: Bruce Troen, MD Host: Eric Tangalos, MD Vitamin D deficiency has been receiving a deluge of media coverage lately, and physicians are likely to hear many related questions from patients, especially long-term care residents and their families. What are the latest developments in vitamin D research, and how can adequate vitamin D levels help prevent falls among our older patients? Even more fundamentally, how do we define vitamin D insufficiency and deficiency?Dr. Bruce Troen,

00:00:00

The Path to FDA Approval for a Therapeutic Cancer...

Healthcare Policy ·

2010/05/27

Host: Bruce Japsen Guest: Mark Frohlich, MD The cancer treatment Provenge, known as a "therapeutic vaccine," was approved by the Food and Drug Administration in April, 2010 as a novel way to attack prostate tumors. But this is more than the story of a new treatment. Host Bruce Japsen learns about the long path to FDA approval for this unique therapy that some see as a watershed development in oncology, from Dr. Mark Frohlich, senior vice president of clinical affairs and chief

00:00:00

Aligning Incentives: Matching Goals to Achieve Better...

Healthcare Policy ·

2010/05/19

Host: William Anderson, PharmD, MBA Guest: Christopher Stanley, MD, MBA How can we align incentives among all healthcare stakeholders to encourage high-quality care, better outcomes and lower overall healthcare costs, ultimately leading to a more efficient healthcare system? How does health information technology provide the infrastructure for measuring outcomes, to provide the necessary data to create incentives for best practices? Dr. Christopher Stanley, senior medical director

00:00:00

Initiating Insulin Therapy for Type 2 Diabetes

Healthcare Policy ·

2010/05/19

Guest: Anne Louise Peters, MD Host: Steven Edelman, MD Initiating insulin therapy for type 2 patients provides its own set of challenges and opportunities. New insulin preparations and a better understanding of insulin physiology may provide physicians more options in effectively tailoring insulin therapy to the needs of their patients. Join host Dr. Steven Edelman and his guest, director of clinical diabetes programs at the University of Southern California, Dr. Anne Peters, as

00:00:00

Potentially Huge Savings When Patients Adhere to...

Healthcare Policy ·

2010/05/12

Guest: Steve Miller, MD Host: Bruce Japsen Doctors know their patients often don't take their medications, whether because they simply forget or procrastinate on obtaining refills. But the lack of compliance with prescriptions has enormous financial ramifications. Dr. Steve Miller, senior vice president & chief medical officer, research and clinical sciences for Express Scripts, one of the nation's largest managers of pharmacy benefits, tells host Bruce Japsen about Express

00:00:00

Medical Journalism and Activism

Healthcare Policy ·

2010/03/30

Guest: Marcia Angell, MD, MACP Host: Martin Samuels, MD Dr. Marcia Angell moved into the field of medical journalism from a career in pathology. She was the first woman to serve as editor-in-chief of the New England Journal of Medicine, and since leaving that post, has written frequently in professional journals and public press on a wide range of topics. Outspoken and frequently controversial, Dr. Angell joins host Dr. Martin Samuels to discuss her career.

323 results

Healthcare Policy

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事